A total of 99 pathways were obtained by KEGG analyses, and majority got involvement with insulin resistance and apoptotic process‐related pathways like P13K–AKT signalling pathway (hsa04151), non‐alcoholic fatty liver disease (NAFLD) (hsa04932), insulin resistance (hsa04931) and apoptosis (hsa04210) (Figure 3B,D). This evidence concerns the gene AKT1 and metabolic dysfunction-associated steatotic liver disease.